Use of the C-terminal octapeptide of cholecystokinin in clinical radiology: II. The small bowel.
The octapeptide of cholecystokinin (C8-CCK) administered by bolus (20 ng/kg) and by infusion (4 ng/kg/min for 30 minutes) doses produced significant shortening of small bowel transit time. Significantly, fewer side effects occurred with the infusion method. The problems encountered in studies of small bowel motility are discussed.
D000328:Adult; D000368:Aged; D001466:Barium Sulfate; D002765:Cholecystography / Q000379:methods*; D002766:Cholecystokinin / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007421:Intestine, Small / Q000000981:diagnostic imaging* / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D001466:Barium Sulfate; D002766:Cholecystokinin